Death receptors — members of the tumor necrosis factor receptor (TNFR) superfamily, including Fas (CD95), TNFR1, DR4, and DR5 — are critical mediators of ...
A new research perspective was published in Volume 13 of Oncoscience on June 3, 2026, titled "The dual axis of tumorigenesis: ...
The PD-1 and PD-L1 inhibitors competitive landscape report delivers important insights into approved as well as ongoing research of 200+ pipeline PD-1 and PD-L1 inhibitor drugs, clinical strategies, ...
Malignant melanoma is one of the most dangerous forms of cancer. Around half of melanomas and about 7% of all other cancers ...
Several types of cancer are triggered by mutations in a protein called BRAF. Researchers at the Paul Scherrer Institute PSI ...
Researchers at the University of Vienna have discovered a key mechanism that enables sea anemones to regenerate into fully ...
Atossa Therapeutics, Inc. (NASDAQ: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of significant unmet clinical ...
Newly discovered protein conformation offers a potential target for cancer drugs. Villigen, 21.07.2026 — Several types of ...
Your intestine completely rebuilds its inner lining every few days—one of the fastest renewal processes in the human body.
A study in mice and in human cells by Stanford Medicine researchers has linked organ aging to the increased inabilityw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results